Medical Program: 2020 Crohn’s & Colitis Congress: Explaining Risk to Patients

2020 Crohn’s & Colitis Congress: Explaining Risk to Patients

ReachMD Healthcare Image
RestartResume

What’s the best way to explain the risk of treatments to our IBD patients? An expert weighs in and shares his approach.

  • Overview

    At the third annual Crohn’s & Colitis Congress in Austin, Texas, Co-Director of the IBD Program and Section Chief of Gastroenterology and Hepatology at the Dartmouth-Hitchcock Medical Center Dr. Corey Siegel sat down with Dr. Matt Birnholz to share his approach to presenting risk data to his IBD patients.

Facebook Comments

Register

We’re glad to see you’re enjoying Crohn's Colitis Professional…
but how about a more personalized experience?

Register for free